These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21509650)

  • 1. Efficacy of adalimumab for a refractory case of relapsing polychondritis with reduction of pro-inflammatory cytokines.
    Nakamura H; Suzuki T; Nagaoka K; Yamasaki S; Tamai M; Hayashi T; Kawakami A
    Mod Rheumatol; 2011 Dec; 21(6):665-8. PubMed ID: 21509650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained response to tocilizumab, anti-IL-6 antibody, following anti-TNF-α failure in a patient with relapsing polychondritis complicated by aortitis.
    Narshi CB; Allard SA
    Rheumatology (Oxford); 2012 May; 51(5):952-3. PubMed ID: 22298790
    [No Abstract]   [Full Text] [Related]  

  • 3. Sweet's syndrome after adalimumab therapy for refractory relapsing polychondritis.
    Keidel S; McColl A; Edmonds S
    BMJ Case Rep; 2011 Dec; 2011():. PubMed ID: 22670004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of relapsing polychondritis with the TNF-alpha antagonist adalimumab.
    Lahmer T; Knopf A; Treiber M; Heemann U; Thuermel K
    Clin Rheumatol; 2010 Nov; 29(11):1331-4. PubMed ID: 20495939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sustained response with tocilizumab in a case of refractory relapsing polychondritis].
    Weber E; Gaultier JB; Paul S; Guichard I; Monard E; Cathébras P
    Rev Med Interne; 2014 Mar; 35(3):196-8. PubMed ID: 24074969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal acute necrotizing eosinophilic myocarditis temporally related to use of adalimumab in a patient with relapsing polychondritis.
    Adamson R; Yazici Y; Katz ES; Greisman SG; Steiger D
    J Clin Rheumatol; 2013 Oct; 19(7):386-9. PubMed ID: 24048108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report.
    Takazono T; Nakamura S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
    BMC Infect Dis; 2014 Feb; 14():114. PubMed ID: 24576098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapsing polychondritis associated with psoriasis vulgaris successfully treated with adalimumab: A case report with published work review.
    Matsuo H; Asahina A; Fukuda T; Umezawa Y; Nakagawa H
    J Dermatol; 2017 Jul; 44(7):826-829. PubMed ID: 28266051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged response to anti-tumour necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis.
    Seymour MW; Home DM; Williams RO; Allard SA
    Rheumatology (Oxford); 2007 Nov; 46(11):1738-9. PubMed ID: 17933796
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustained remission of pediatric relapsing polychondritis with adalimumab.
    Navarrete VM; Lebrón CV; de Miera FJ; Candau CP; Sarabia FN
    J Clin Rheumatol; 2014 Jan; 20(1):45-6. PubMed ID: 24356482
    [No Abstract]   [Full Text] [Related]  

  • 11. Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis.
    Kawai M; Hagihara K; Hirano T; Shima Y; Kuwahara Y; Arimitsu J; Narazaki M; Ogata A; Kawase I; Kishimoto T; Tanaka T
    Rheumatology (Oxford); 2009 Mar; 48(3):318-9. PubMed ID: 19106169
    [No Abstract]   [Full Text] [Related]  

  • 12. Infliximab in relapsing polychondritis.
    de Barros AP; Nakamura NA; Santana Tde F; Motta JQ; Bianchi WA
    Rev Bras Reumatol; 2010; 50(2):211-6. PubMed ID: 21125156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of relapsing polychondritis preceded by inner ear involvement.
    Kumakiri K; Sakamoto T; Karahashi T; Mineta H; Takebayashi S
    Auris Nasus Larynx; 2005 Mar; 32(1):71-6. PubMed ID: 15882830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of tocilizumab for psychiatric symptoms associated with relapsing polychondritis: the first case report and review of the literature.
    Liu L; Liu S; Guan W; Zhang L
    Rheumatol Int; 2016 Aug; 36(8):1185-9. PubMed ID: 27260262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of severe MAGIC syndrome treated successfully with the tumor necrosis factor-alpha inhibitor infliximab.
    Geissal ED; Wernick R
    J Clin Rheumatol; 2010 Jun; 16(4):185-7. PubMed ID: 20414125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapsing polychondritis: response to tocilizumab and association with colitis.
    Plunkett M; Lamont D; Brooker J; White D
    J Clin Rheumatol; 2013 Oct; 19(7):415-7. PubMed ID: 24048111
    [No Abstract]   [Full Text] [Related]  

  • 17. Refractory relapsing polychondritis treated with serial success with interleukin 6 receptor blockade.
    Wallace ZS; Stone JH
    J Rheumatol; 2013 Jan; 40(1):100-1. PubMed ID: 23280172
    [No Abstract]   [Full Text] [Related]  

  • 18. Adalimumab for the treatment of refractory acne conglobata.
    Sand FL; Thomsen SF
    JAMA Dermatol; 2013 Nov; 149(11):1306-7. PubMed ID: 24048280
    [No Abstract]   [Full Text] [Related]  

  • 19. Biologics in relapsing polychondritis: a case series.
    Moulis G; Sailler L; Pugnet G; Astudillo L; Arlet P
    Clin Exp Rheumatol; 2013; 31(6):937-9. PubMed ID: 24021708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary type II collagen neoepitope as an outcome measure for relapsing polychondritis.
    Kraus VB; Stabler T; Le ET; Saltarelli M; Allen NB
    Arthritis Rheum; 2003 Oct; 48(10):2942-8. PubMed ID: 14558101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.